Memorial Sloan Kettering hematologist Malin Hultcrantz

Malin Hultcrantz, MD, PhD

Myeloma Specialist

Areas of Expertise

Conditions I Treat

  • Multiple myeloma and other plasma-cell diseases
  • Monoclonal gammopathy of undetermined significance (MGUS)
  • Smoldering multiple myeloma (SMM)

My Specialties

  • Clinical trials
  • Immunotherapy
Dr. Hultcrantz's Office Information
Languages: English & Swedish
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified hematologist who specializes in the treatment of multiple myeloma and related plasma cell disorders including the precursor disorders monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma.

Together with my colleagues at MSK, I am focused on further optimizing treatment strategies for people with multiple myeloma. We offer a variety of modern treatments including clinic trials and novel immunotherapies. We are also working on measures to continue to improve patients’ quality of life while receiving treatment for multiple myeloma.

Additionally, I have a particular interest in studying mechanisms and markers of progression from precursor disease to multiple myeloma. As part of this effort, we are developing targeted genomic tests for disease characterization and measurement of minimal residual disease. Better understanding of disease biology allows for better risk stratification and personalized treatment including early treatment for patients with high-risk precursor disease.

What I Do at MSK

I’m a myeloma specialist, which is a doctor with special training in diagnosing and treating myeloma (MY-eh-LOH-muh). This cancer starts in a type of white blood cell.

  • Assistant Attending Physician
Areas of Expertise

Conditions I Treat

  • Multiple myeloma and other plasma-cell diseases
  • Monoclonal gammopathy of undetermined significance (MGUS)
  • Smoldering multiple myeloma (SMM)

My Specialties

  • Clinical trials
  • Immunotherapy
Education & Honors

Education

  • MD, Karolinska Institute
  • PhD, Karolinska Institute

Residencies

  • Internal Medicine - University Hospital Orebro, Sweden

Fellowships

  • Hematology/Internal Medicine - Karolinska University Hospital
  • Advanced Oncology Fellowship - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Hematology
  • Internal Medicine

Awards and Honors

  • Multiple Myeloma Research Foundation, Research Fellow Award (2015)
  • International Postdoc Award, Swedish Research Council (2015)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9062— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Myeloma Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Hultcrantz’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Malin Hultcrantz discloses the following relationships and financial interests:

  • Aptitude Health
    Professional Services and Activities
  • Bristol-Myers Squibb
    Professional Services and Activities
  • Curio Science LLC
    Professional Services and Activities
  • GlaxoSmithKline
    Professional Services and Activities
  • Janssen Biotech, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: